Replication potentials of vif variant viruses generated from monkey cell-tropic HIV-1 derivative clones NL-DT5/NL-DT5R

Microbes and Infection

Volumn 10, Issue 10-11, 2008, Pages 1218-1222

  Hatcho, Kazuki ^a   Kamada, Kazuya ^a   Yamashita, Tomoki ^a   Adachi, Akio ^a   Nomaguchi, Masako ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

APOBEC3F; APOBEC3G; HIV 1; SIV; Species tropism; Vif

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; VIF PROTEIN;

ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIROGENESIS; VIRUS INFECTIVITY;

ANIMALS; CELL LINE; CLONING, MOLECULAR; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; GENES, VIF; HAPLORHINI; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MUTATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 54049106466     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.06.007     Document Type: Article

References (17)

1. Kamada K., Igarashi T., Martin M.A., Khamsri B., Hatcho K., Yamashita T., Fujita M., Uchiyama T., and Adachi A. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl. Acad. Sci. USA. 103 (2006) 16959-16964
2. Hatziioannou T., Princiotta M., Piatak Jr. M., Yuan F., Zhang F., Lifson J.D., and Bieniasz P.D. Generation of simian-tropic HIV-1 by restriction factor evasion. Science. 314 (2006) 95
3. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
4. Shibata R., Kawamura M., Sakai H., Hayami M., Ishimoto A., and Adachi A. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65 (1991) 3514-3520
5. Fujita M., Sakurai A., Yoshida A., Miyaura M., Koyama A.H., Sakai K., and Adachi A. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif. J. Virol. 77 (2003) 1626-1632
6. Fujita M., Akari H., Sakurai A., Yoshida A., Chiba T., Tanaka K., Strebel K., and Adachi A. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation. Microbes Infect. 6 (2004) 791-798
7. Lebkowski J.S., Clancy S., and Calos M.P. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature. 317 (1985) 169-171
8. Akari H., Fukumori T., Iida S., and Adachi A. Induction of apoptosis in herpesvirus saimiri-immortalized T lymphocytes by blocking interaction of CD28 with CD80/CD86. Biochem. Biophys. Res. Commun. 263 (1999) 352-356
9. Folks T., Benn S., Rabson A., Theodore T., Hoggan M.D., Martin M., Lightfoote M., and Sell K. Characterization of a continuous T-cell line susceptible to the cytopathic effects of acquired immune deficiency syndrome (AIDS)-associated retrovirus. Proc. Natl. Acad. Sci. USA. 82 (1985) 4539-4543
10. Willey R.L., Smith D.H., Lasky L.A., Theodore T.S., Earl P.L., Moss B., Capon D.J., and Martin M.A. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62 (1988) 139-147
11. Mariani R., Chen D., Schröfelbauer B., Navarro F., König R., Bollman B., Münk C., Nymark-McMahon H., and Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell. 114 (2003) 21-31
12. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., and Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA. 91 (1994) 9564-9568
13. Connor R.I., Chen B.K., Choe S., and Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206 (1995) 935-944
14. Schröfelbauer B., Senger T., Manning G., and Landau N.R. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G. J. Virol. 80 (2006) 5984-5991
15. Zheng Y.H., Irwin D., Kurosu T., Tokunaga K., Sata T., and Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78 (2004) 6073-6076
16. Wiegand H.L., Doehle B.P., Bogerd H.P., and Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23 (2004) 2451-2458
17. Virgen C.A., and Hatziioannou T. Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins. J. Virol. 81 (2007) 13932-13937